In vivo study of iron oxide-calcium phosphate composite nanoparticles for delivery to atherosclerosis. (31st May 2021)

• Record Type: Journal Article
• Authors: Nakamura, Maki; Kosuge, Hisanori; Oyane, Ayako; Kuroiwa, Kiyoko; Shimizu, Yoshiki; Aonuma, Kazutaka
• Is Part Of: Nanotechnology. Volume 32:Number 34(2021)
• Publication Date: 2021-05-31
• Subjects: iron oxide nanocrystal -- calcium phosphate -- composite nanoparticle -- macrophage -- atherosclerosis -- imaging; Nanotechnology -- Periodicals; Nanotechnology -- Periodicals; Nanotechnology; Publications périodiques; Nanotechnologies; Periodicals; 620.5
• DOI: 10.1088/1361-6528/ac007d
• Languages: English
• ISSNs: 0957-4484

Abstract

Abstract: Atherosclerosis is a macrophage-related inflammatory disease that remains a leading cause of death worldwide. Magnetic iron oxide (IO) nanocrystals are clinically used as magnetic resonance imaging contrast agents and their application as a detection agent for macrophages in arterial lesions has been studied extensively. We recently fabricated heparin-modified calcium phosphate (CaP) nanoparticles loaded with a large number of IO nanocrystals via coprecipitation from a supersaturated CaP solution supplemented with heparin and ferucarbotran (IO nanocrystals coated with carboxydextran). In this study, we further increased the content of IO nanocrystals in the heparin-modified IO–CaP composite nanoparticles by increasing the ferucarbotran concentration in the supersaturated CaP solution. The increase in nanoparticle IO content caused a decrease in particle diameter without impairing its dispersibility; the nanoparticles remained dispersed in water for up to 2 h due to electrostatic repulsion between particles due to the surface modification with heparin. The nanoparticles were more effectively taken up by murine RAW264.7 macrophages compared to free ferucarbotran without showing significant cytotoxicity. A preliminary in vivo study showed that the nanoparticles injected intravenously into mice delivered more IO nanocrystals to macrophage-rich carotid arterial lesions than free ferucarbotran. Our nanoparticles have potential as a delivery agent of IO nanocrystals to macrophages in arterial lesions.